OPEXA THERAPEUTICS OPXA (NASDAQ)

$ 1.60
19:10
Change: unch (unch%)
Volume: 6,029

Avg. Volume: 33711
P/E Ratio: 0
EPS (Annual): -2.26
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 6,700
Institutional Shareholders: 27.14%
Last: 1.60
Change: unch (unch%)
Prev. Close: 1.60
Open: 1.55
Day's Range: 1.53 - 1.60
52wk Range: 0.77 - 5.10
Market Value: 14,070
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -71.25%
Total Return Last 3 Years: -156.06%
Total Return Last 5 Years: -84.44%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on OPXA

Opexa Therapeutics 4Q Loss Widens

(THE WOODLANDS, Texas)Biotechnology company Opexa Therapeutics Inc. said Tuesday its 2007 loss widened on higher research and development expenses. The company lost $14.7 million, or $2.19 per share, co...READ MORE
Mar 18, 2008 9:22AM
Keywords: OPXA
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +6.50 53.92
GILEAD SCIENCES +37.60 52.70
GENENTECH INC +36.30 93.73
CELGENE CP +22.00 70.45
BIOGEN IDEC INC +29.90 71.38